Evolutionary gamut of in vivo Gag substitutions during early HIV-1 subtype C infection

Virology

Volumn 421, Issue 2, 2011, Pages 119-128

  Novitsky, Vladimir ^a,b   Wang, Rui ^c   Baca, Jeannie ^a   Margolin, Lauren ^a   McLane, Mary F ^a   Moyo, Sikhulile ^b   van Widenfelt, Erik ^b   Makhema, Joseph ^a,b   Essex, M ^a,b  

^a Harvard AIDS Institute   (United States)

^b BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Dynamics; Gag; HIV 1 subtype C; Mutation; Spectrum

Indexed keywords

GAG PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS DNA; VIRUS RNA;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONSENSUS SEQUENCE; CYTOTOXIC T LYMPHOCYTE; DNA TEMPLATE; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C INFECTION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERTANT; SEROCONVERSION; UNINDEXED SEQUENCE;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; COHORT STUDIES; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, RNA; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80355133201     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.09.020     Document Type: Article

References (68)

1. Allen T.M., Altfeld M., Yu X.G., O'Sullivan K.M., Lichterfeld M., Le Gall S., John M., Mothe B.R., Lee P.K., Kalife E.T., Cohen D.E., Freedberg K.A., Strick D.A., Johnston M.N., Sette A., Rosenberg E.S., Mallal S.A., Goulder P.J.R., Brander C., Walker B.D. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J. Virol. 2004, 78:7069-7078.
2. Allen T.M., Altfeld M., Geer S.C., Kalife E.T., Moore C., O'Sullivan K.M., DeSouza I., Feeney M.E., Eldridge R.L., Maier E.L., Kaufmann D.E., Lahaie M.P., Reyor L., Tanzi G., Johnston M.N., Brander C., Draenert R., Rockstroh J.K., Jessen H., Rosenberg E.S., Mallal S.A., Walker B.D. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J. Virol. 2005, 79:13239-13249.
3. Betts M.R., Ambrozak D.R., Douek D.C., Bonhoeffer S., Brenchley J.M., Casazza J.P., Koup R.A., Picker L.J. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 2001, 75:11983-11991.
4. Bhattacharya T., Daniels M., Heckerman D., Foley B., Frahm N., Kadie C., Carlson J., Yusim K., McMahon B., Gaschen B., Mallal S., Mullins J.I., Nickle D.C., Herbeck J., Rousseau C., Learn G.H., Miura T., Brander C., Walker B., Korber B. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 2007, 315:1583-1586.
5. Boaz M.J., Waters A., Murad S., Easterbrook P.J., Vyakarnam A. Presence of HIV-1 Gag-specific IFN-gamma(+)IL-2(+) and CD28(+)IL-2(+) CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 2002, 169:6376-6385.
6. Borghans J.A.M., MÃilgaard A., de Boer R.J., KeÅÿmir C. HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS One 2007, 2:e920.
7. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., Nelson J.A., Gairin J.E., Hahn B.H., Oldstone M.B., Shaw G.M. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 1997, 3:205-211.
8. Brockman M.A., Schneidewind A., Lahaie M., Schmidt A., Miura T., Desouza I., Ryvkin F., Derdeyn C.A., Allen S., Hunter E., Mulenga J., Goepfert P.A., Walker B.D., Allen T.M. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 2007, 81:12608-12618.
9. Brumme Z.L., Brumme C.J., Heckerman D., Korber B.T., Daniels M., Carlson J., Kadie C., Bhattacharya T., Chui C., Szinger J., Mo T., Hogg R.S., Montaner J.S., Frahm N., Brander C., Walker B.D., Harrigan P.R. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog. 2007, 3:e94.
10. Brumme Z.L., Brumme C.J., Carlson J., Streeck H., John M., Eichbaum Q., Block B.L., Baker B., Kadie C., Markowitz M., Jessen H., Kelleher A.D., Rosenberg E., Kaldor J., Yuki Y., Carrington M., Allen T.M., Mallal S., Altfeld M., Heckerman D., Walker B.D. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J. Virol. 2008, 82:9216-9227.
11. Brumme Z.L., Tao I., Szeto S., Brumme C.J., Carlson J.M., Chan D., Kadie C., Frahm N., Brander C., Walker B., Heckerman D., Harrigan P.R. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. AIDS 2008, 22:1277-1286.
12. Carrington M., Nelson G.W., Martin M.P., Kissner T., Vlahov D., Goedert J.J., Kaslow R., Buchbinder S., Hoots K., O'Brien S.J. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999, 283:1748-1752.
13. Chopera D.R., Woodman Z., Mlisana K., Mlotshwa M., Martin D.P., Seoighe C., Treurnicht F., de Rosa D.A., Hide W., Karim S.A., Gray C.M., Williamson C. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathogens 2008, 4:e1000033.
14. Crawford H., Prado J.G., Leslie A., Hue S., Honeyborne I., Reddy S., van der Stok M., Mncube Z., Brander C., Rousseau C., Mullins J.I., Kaslow R., Goepfert P., Allen S., Hunter E., Mulenga J., Kiepiela P., Walker B.D., Goulder P.J. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 2007, 81:8346-8351.
15. Davenport M.P., Loh L., Petravic J., Kent S.J. Rates of HIV immune escape and reversion: implications for vaccination. Trends Microbiol. 2008, 16:561-566.
16. Duda A., Lee-Turner L., Fox J., Robinson N., Dustan S., Kaye S., Fryer H., Carrington M., McClure M., McLean A.R., Fidler S., Weber J., Phillips R.E., Frater A.J. HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J. Virol. 2009, 83:1228-1239.
17. Edwards B.H., Bansal A., Sabbaj S., Bakari J., Mulligan M.J., Goepfert P.A. Magnitude of functional CD8+ T-cell responses to the Gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 2002, 76:2298-2305.
18. Feeney M.E., Tang Y., Roosevelt K.A., Leslie A.J., McIntosh K., Karthas N., Walker B.D., Goulder P.J.R. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J. Virol. 2004, 78:8927-8930.
19. Fellay J., Shianna K.V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., Cozzi-Lepri A., De Luca A., Easterbrook P., Francioli P., Mallal S., Martinez-Picado J., Miro J.M., Obel N., Smith J.P., Wyniger J., Descombes P., Antonarakis S.E., Letvin N.L., McMichael A.J., Haynes B.F., Telenti A., Goldstein D.B. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317:944-947.
20. Friedrich T.C., Dodds E.J., Yant L.J., Vojnov L., Rudersdorf R., Cullen C., Evans D.T., Desrosiers R.C., Mothe B.R., Sidney J., Sette A., Kunstman K., Wolinsky S., Piatak M., Lifson J., Hughes A.L., Wilson N., O'Connor D.H., Watkins D.I. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 2004, 10:275-281.
21. Friedrich T.C., Frye C.A., Yant L.J., O'Connor D.H., Kriewaldt N.A., Benson M., Vojnov L., Dodds E.J., Cullen C., Rudersdorf R., Hughes A.L., Wilson N., Watkins D.I. Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. J. Virol. 2004, 78:2581-2585.
22. Friedrich T.C., McDermott A.B., Reynolds M.R., Piaskowski S., Fuenger S., de Souza I.P., Rudersdorf R., Cullen C., Yant L.J., Vojnov L., Stephany J., Martin S., O'Connor D.H., Wilson N., Watkins D.I. Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts. J. Virol. 2004, 78:10064-10073.
23. Geels M.J., Cornelissen M., Schuitemaker H., Anderson K., Kwa D., Maas J., Dekker J.T., Baan E., Zorgdrager F., van den Burg R., van Beelen M., Lukashov V.V., Fu T.M., Paxton W.A., van der Hoek L., Dubey S.A., Shiver J.W., Goudsmit J. Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. J. Virol. 2003, 77:12430-12440.
24. Geels M.J., Jansen C.A., Baan E., De Cuyper I.M., van Schijndel G.J., Schuitemaker H., Goudsmit J., Pollakis G., Miedema F., Paxton W.A., van Baarle D. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals. Virology 2006, 345:209-219.
25. Geldmacher C., Currier J.R., Herrmann E., Haule A., Kuta E., McCutchan F., Njovu L., Geis S., Hoffmann O., Maboko L., Williamson C., Birx D., Meyerhans A., Cox J., Hoelscher M. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J. Virol. 2007, 81:2440-2448.
26. Goepfert P.A., Lumm W., Farmer P., Matthews P., Prendergast A., Carlson J.M., Derdeyn C.A., Tang J., Kaslow R.A., Bansal A., Yusim K., Heckerman D., Mulenga J., Allen S., Goulder P.J., Hunter E. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J. Exp. Med. 2008, 205:1009-1017.
27. Goonetilleke N., Liu M.K., Salazar-Gonzalez J.F., Ferrari G., Giorgi E., Ganusov V.V., Keele B.F., Learn G.H., Turnbull E.L., Salazar M.G., Weinhold K.J., Moore S., Letvin N., Haynes B.F., Cohen M.S., Hraber P., Bhattacharya T., Borrow P., Perelson A.S., Hahn B.H., Shaw G.M., Korber B.T., McMichael A.J. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 2009, 206:1253-1272.
28. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids. Symp. Ser. 1999, 41:95-98.
29. Kaslow R.A., Carrington M., Apple R., Park L., Munoz A., Saah A.J., Goedert J.J., Winkler C., O'Brien S.J., Rinaldo C., Detels R., Blattner W., Phair J., Erlich H., Mann D.L. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 1996, 2:405-411.
30. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., de Pierres C., Mncube Z., Mkhwanazi N., Bishop K., van der Stok M., Nair K., Khan N., Crawford H., Payne R., Leslie A., Prado J., Prendergast A., Frater J., McCarthy N., Brander C., Learn G.H., Nickle D., Rousseau C., Coovadia H., Mullins J.I., Heckerman D., Walker B.D., Goulder P. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 2007, 13:46-53.
31. Klein M.R., van der Burg S.H., Hovenkamp E., Holwerda A.M., Drijfhout J.W., Melief C.J., Miedema F. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. J. Gen. Virol. 1998, 79(Pt 9):2191-2201.
32. Koenig S., Conley A.J., Brewah Y.A., Jones G.M., Leath S., Boots L.J., Davey V., Pantaleo G., Demarest J.F., Carter C., et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1995, 1:330-336.
33. Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., Tang Y., Holmes E.C., Allen T., Prado J.G., Altfeld M., Brander C., Dixon C., Ramduth D., Jeena P., Thomas S.A., St John A., Roach T.A., Kupfer B., Luzzi G., Edwards A., Taylor G., Lyall H., Tudor-Williams G., Novelli V., Martinez-Picado J., Kiepiela P., Walker B.D., Goulder P.J. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 2004, 10:282-289.
34. Leslie A., Kavanagh D., Honeyborne I., Pfafferott K., Edwards C., Pillay T., Hilton L., Thobakgale C., Ramduth D., Draenert R., Le Gall S., Luzzi G., Edwards A., Brander C., Sewell A.K., Moore S., Mullins J., Moore C., Mallal S., Bhardwaj N., Yusim K., Phillips R., Klenerman P., Korber B., Kiepiela P., Walker B., Goulder P. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J. Exp. Med. 2005, 201:891-902.
35. Li B., Gladden A.D., Altfeld M., Kaldor J.M., Cooper D.A., Kelleher A.D., Allen T.M. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J. Virol. 2007, 81:193-201.
36. Liu Y., McNevin J., Zhao H., Tebit D.M., Troyer R.M., McSweyn M., Ghosh A.K., Shriner D., Arts E.J., McElrath M.J., Mullins J.I. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. J. Virol. 2007, 81:12179-12188.
37. Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeyborne I., Crawford H., Matthews P., Pillay T., Rousseau C., Mullins J.I., Brander C., Walker B.D., Stuart D.I., Kiepiela P., Goulder P. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 2006, 80:3617-3623.
38. Masemola A., Mashishi T., Khoury G., Mohube P., Mokgotho P., Vardas E., Colvin M., Zijenah L., Katzenstein D., Musonda R., Allen S., Kumwenda N., Taha T., Gray G., McIntyre J., Karim S.A., Sheppard H.W., Gray C.M. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J. Virol. 2004, 78:3233-3243.
39. Matthews P.C., Prendergast A., Leslie A., Crawford H., Payne R., Rousseau C., Rolland M., Honeyborne I., Carlson J., Kadie C., Brander C., Bishop K., Mlotshwa N., Mullins J.I., Coovadia H., Ndung'u T., Walker B.D., Heckerman D., Goulder P.J. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J. Virol. 2008, 82:8548-8559.
40. Migueles S.A., Laborico A.C., Imamichi H., Shupert W.L., Royce C., McLaughlin M., Ehler L., Metcalf J., Liu S., Hallahan C.W., Connors M. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J. Virol. 2003, 77:6889-6898.
41. Moore C.B., John M., James I.R., Christiansen F.T., Witt C.S., Mallal S.A. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002, 296:1439-1443.
42. Ndongala M.L., Peretz Y., Boulet S., Doroudchi M., Yassine-Diab B., Boulassel M.R., Rouleau D., Tremblay C., Leblanc R., Routy J.P., Sekaly R.P., Bernard N.F. HIV Gag p24 specific responses secreting IFN-gamma and/or IL-2 in treatment-naive individuals in acute infection early disease (AIED) are associated with low viral load. Clin. Immunol. 2009, 131:277-287.
43. Novitsky V., Smith U.R., Gilbert P., McLane M.F., Chigwedere P., Williamson C., Ndung'u T., Klein I., Chang S.Y., Peter T., Thior I., Foley B.T., Gaolekwe S., Rybak N., Gaseitsiwe S., Vannberg F., Marlink R., Lee T.H., Essex M. HIV-1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?. J. Virol. 2002, 76:5435-5451.
44. Novitsky V., Gilbert P., Peter T., McLane M.F., Gaolekwe S., Rybak N., Thior I., Ndung'u T., Marlink R., Lee T.H., Essex M. Association between virus-specific T-cell responses and plasma viral load in HIV-1 subtype C infection. J. Virol. 2003, 77:882-890.
45. Novitsky V.A., Gilbert P.B., Shea K., McLane M.F., Rybak N., Klein I., Thior I., Ndung'u T., Lee T.H., Essex M.E. Interactive association of proviral load and IFN-gamma-secreting T cell responses in HIV-1C infection. Virology 2006, 349:142-155.
46. Novitsky V., Woldegabriel E., Wester C., McDonald E., Rossenkhan R., Ketunuti M., Makhema J., Seage G.R., Essex M. Identification of primary HIV-1C infection in Botswana. NIHMSID # 79283. AIDS Care 2008, 20:806-811.
47. Novitsky V., Lagakos S., Herzig M., Bonney C., Kebaabetswe L., Rossenkhan R., Nkwe D., Margolin L., Musonda R., Moyo S., Woldegabriel E., van Widenfelt E., Makhema J., Essex M. Evolution of proviral gp120 over the first year of HIV-1 subtype C infection. NIHMSID # 79286. Virology 2009, 383:47-59.
48. Novitsky V., Wang R., Kebaabetswe L., Greenwald J., Rossenkhan R., Moyo S., Musonda R., Woldegabriel E., Lagakos S., Essex M. Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection. J. Acquir. Immune Defic. Syndr. 2009, 52:265-272.
49. Novitsky V., Wang R., Margolin L., Baca J., Kebaabetswe L., Rossenkhan R., Bonney C., Herzig M., Nkwe D., Moyo S., Musonda R., Woldegabriel E., van Widenfelt E., Makhema J., Lagakos S., Essex M. Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection. PLoS One 2009, 4:e7727.
50. Novitsky V., Woldegabriel E., Kebaabetswe L., Rossenkhan R., Mlotshwa B., Bonney C., Finucane M., Musonda R., Moyo S., Wester C., van Widenfelt E., Makhema J., Lagakos S., Essex M. Viral load and CD4+ T cell dynamics in primary HIV-1 subtype C infection. J. Acquir. Immune Defic. Syndr. 2009, 50:65-76.
51. Novitsky V., Wang R., Lagakos S., Essex M. HIV-1 subtype C phylodynamics in the global epidemic. Viruses 2010, 2:33-54.
52. Novitsky V., Wang R., Margolin L., Baca J., Moyo S., Musonda R., Essex M. Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection. Virology 2010, 403:37-46.
53. Novitsky V., Wang R., Essex M. Phylodynamics of HIV-1 subtype C Gag in the global epidemic. Abstract 49, 17th International HIV Dynamics & Evolution. University of California, San Diego, Asilomar Conference Grounds - Monterey, CA 2010.
54. O'Brien S.J., Nelson G.W. Human genes that limit AIDS. Nat. Genet. 2004, 36:565-574.
55. Oxenius A., Price D.A., Trkola A., Edwards C., Gostick E., Zhang H.T., Easterbrook P.J., Tun T., Johnson A., Waters A., Holmes E.C., Phillips R.E. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies. J. Infect. Dis. 2004, 190:713-721.
56. Peyerl F.W., Barouch D.H., Letvin N.L. Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytes. Viral. Immunol. 2004, 17:144-151.
57. Peyerl F.W., Bazick H.S., Newberg M.H., Barouch D.H., Sodroski J., Letvin N.L. Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope. J. Virol. 2004, 78:13901-13910.
58. Phillips R.E., Rowland-Jones S., Nixon D.F., Gotch F.M., Edwards J.P., Ogunlesi A.O., Elvin J.G., Rothbard J.A., Bangham C.R., Rizza C.R., McMichael A.J. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991, 354:453-459.
59. Price D.A., Goulder P.J., Klenerman P., Sewell A.K., Easterbrook P.J., Troop M., Bangham C.R., Phillips R.E. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1890-1895.
60. Ramduth D., Chetty P., Mngquandaniso N.C., Nene N., Harlow J.D., Honeyborne I., Ntumba N., Gappoo S., Henry C., Jeena P., Addo M.M., Altfeld M., Brander C., Day C., Coovadia H., Kiepiela P., Goulder P., Walker B. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. J. Infect. Dis. 2005, 192:1588-1596.
61. Ray S.C. MargFreq 2008, SCRoftware. http://sray.med.som.jhmi.edu/SCRoftware/MargFreq.
62. Rolland M., Heckerman D., Deng W., Rousseau C.M., Coovadia H., Bishop K., Goulder P.J., Walker B.D., Brander C., Mullins J.I. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One 2008, 3:e1424.
63. Rose P.P., Korber B.T. Detecting hypermutations in viral sequences with an emphasis on G → A hypermutation. Bioinformatics 2000, 16:400-401.
64. Rousseau C.M., Daniels M.G., Carlson J.M., Kadie C., Crawford H., Prendergast A., Matthews P., Payne R., Rolland M., Raugi D.N., Maust B.S., Learn G.H., Nickle D.C., Coovadia H., Ndung'u T., Frahm N., Brander C., Walker B.D., Goulder P.J., Bhattacharya T., Heckerman D.E., Korber B.T., Mullins J.I. HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load. J. Virol. 2008, 82:6434-6446.
65. Schneidewind A., Brockman M.A., Yang R., Adam R.I., Li B., Le Gall S., Rinaldo C.R., Craggs S.L., Allgaier R.L., Power K.A., Kuntzen T., Tung C.S., LaBute M.X., Mueller S.M., Harrer T., McMichael A.J., Goulder P.J., Aiken C., Brander C., Kelleher A.D., Allen T.M. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 2007, 81:12382-12393.
66. Serwanga J., Shafer L.A., Pimego E., Auma B., Watera C., Rowland S., Yirrell D., Pala P., Grosskurth H., Whitworth J., Gotch F., Kaleebu P. Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naive Ugandans. PLoS One 2009, 4:e4188.
67. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 1999, 73:10489-10502.
68. Zuniga R., Lucchetti A., Galvan P., Sanchez S., Sanchez C., Hernandez A., Sanchez H., Frahm N., Linde C.H., Hewitt H.S., Hildebrand W., Altfeld M., Allen T.M., Walker B.D., Korber B.T., Leitner T., Sanchez J., Brander C. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J. Virol. 2006, 80:3122-3125.